Listed

Allurion Technologies, Inc.

ALUROTCCIK 1964979HealthcareFiscal year ends Dec 31

Reports and events: 104 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Allurion Technologies, Inc., Reports and events
FiledFormWhat it isAccession number
2026-09-0200:03 ETSCHEDULE 13D/AOwnership report, active investor, amended0001493215-26-000166
2026-08-2421:30 ET8-K5.02 Departure or appointment of officers or directors0001193125-26-363811
2026-07-2420:50 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-26-316202
2026-07-2321:19 ETSCHEDULE 13D/AOwnership report, active investor, amended0001493215-26-000135
2026-07-2321:00 ET8-K5.02 Departure or appointment of officers or directors0001193125-26-314263
2026-07-0712:05 ET8-K5.02 Departure or appointment of officers or directors0001193125-26-296918
2026-06-3021:00 ET8-K5.02 Departure or appointment of officers or directors0001193125-26-290772
2026-06-1720:35 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-274250
2026-05-2720:35 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001193125-26-242009
2026-05-1520:30 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-226960
2026-03-3012:30 ET10-KAnnual reportPeriod 2025-12-310001193125-26-130483
2026-03-1221:11 ET8-K3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-104434
2026-03-0221:20 ETSCHEDULE 13D/AOwnership report, active investor, amended0001493215-26-000066
2026-03-0214:18 ET8-K3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-084412
2026-02-2513:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0001193125-26-068667
2026-02-2314:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-062599
2026-01-1221:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-010462
2025-12-1922:00 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-25-327032
2025-11-2421:05 ETDEF 14AProxy statementPeriod 2025-12-180001193125-25-293675
2025-11-1721:14 ET10-QQuarterly reportPeriod 2025-09-300001193125-25-284630
2025-11-1322:20 ETSCHEDULE 13D/AOwnership report, active investor, amended0001493215-25-000030
2025-11-1213:15 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-276066
2025-11-0722:21 ETSCHEDULE 13D/AOwnership report, active investor, amended0001493215-25-000016
2025-10-0320:30 ET8-K5.02 Departure or appointment of officers or directors0001193125-25-230301
2025-08-2820:42 ET10-Q/AQuarterly report, amendedPeriod 2024-09-300000950170-25-112011
2025-08-2820:38 ET10-Q/AQuarterly report, amendedPeriod 2024-06-300000950170-25-112000
2025-08-2820:34 ET10-Q/AQuarterly report, amendedPeriod 2024-03-310000950170-25-111984
2025-08-2820:30 ET10-K/AAnnual report, amendedPeriod 2023-12-310000950170-25-111978
2025-08-1921:18 ET10-QQuarterly reportPeriod 2025-06-300000950170-25-110188
2025-08-1920:53 ET10-Q/AQuarterly report, amendedPeriod 2025-03-310000950170-25-110164
2025-08-1920:30 ET10-K/AAnnual report, amendedPeriod 2024-12-310000950170-25-110133
2025-08-1421:22 ET8-K4.02 Non-reliance on financial statements0001193125-25-180926
2025-08-1312:15 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-25-107634
2025-08-0722:44 ET8-K2.02 Results of operations; 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-25-104347
2025-05-1520:15 ET10-QQuarterly reportPeriod 2025-03-310000950170-25-072662
2025-05-1412:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-070934
2025-04-1722:34 ETSCHEDULE 13D/AOwnership report, active investor, amended0000950170-25-055659
2025-04-1720:15 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0000950170-25-055398
2025-04-1021:07 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000950170-25-052927
2025-04-0321:19 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-072475
2025-03-2720:08 ET10-KAnnual reportPeriod 2024-12-310000950170-25-046063
2025-03-2612:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-044805
2025-03-2410:09 ETDEF 14AProxy statementPeriod 2025-04-040001193125-25-060793
2025-02-2421:15 ETSCHEDULE 13D/AOwnership report, active investor, amended0000950170-25-025629
2025-02-2121:06 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-031990
2025-02-1322:13 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-026187
2025-01-2921:10 ETSCHEDULE 13D/AOwnership report, active investor, amended0000950170-25-010486
2025-01-2802:57 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-013703
2025-01-1601:22 ETSCHEDULE 13D/AOwnership report, active investor, amended0000950170-25-006412
2025-01-1700:24 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-25-007863

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.